Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Juvenile cataract - microcornea - renal glucosuria is an extremely rare autosomal dominant association reported in a single Swiss family and characterized clinically by juvenile cataract associated with bilateral microcornea, and renal glucosuria without other renal tubular defects.
Features include common findings: Cataract, Microcornea, and Glycosuria.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Cataract |
Age of onset: adolescence.
SLC16A12 function has not been fully characterized.
Juvenile cataract-microcornea-renal glucosuria syndrome is associated with mutations in the SLC16A12 gene on chromosome 10.
Genetic testing for SLC16A12 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for juvenile cataract-microcornea-renal glucosuria syndrome has been reported in the published literature.
Phenotype severity distribution: 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for juvenile cataract-microcornea-renal glucosuria syndrome.
102 publications have been identified in PubMed for juvenile cataract-microcornea-renal glucosuria syndrome. Research spans Epidemiology / Natural History (34%), Clinical Trial Publication (29%), and Review / Meta-Analysis (20%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 32 | 34% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Clinical study results |
27 |
29% |
Research summaries | 19 | 20% |
Testing and diagnosis research | 7 | 8% |
Laboratory research | 6 | 6% |
Patient case studies | 2 | 2% |
Nakagawa S (2026). [PMID: 41533258](https://pubmed.ncbi.nlm.nih.gov/41533258/). *Jpn J Ophthalmol*. [Clinical Trial Publication]
Padhy D (2026). [PMID: 41338941](https://pubmed.ncbi.nlm.nih.gov/41338941/). *Br J Ophthalmol*. [Epidemiology / Natural History]
Josef JD (2026). [PMID: 41381288](https://pubmed.ncbi.nlm.nih.gov/41381288/). *Trends Pharmacol Sci*. [Review / Meta-Analysis]
Chen X (2026). [PMID: 41231447](https://pubmed.ncbi.nlm.nih.gov/41231447/). *JAMA Ophthalmol*. [Clinical Trial Publication]
Baba T (2026). [PMID: 41545172](https://pubmed.ncbi.nlm.nih.gov/41545172/). *Br J Ophthalmol*. [Epidemiology / Natural History]
Hamilton NR (2026). [PMID: 40914206](https://pubmed.ncbi.nlm.nih.gov/40914206/). *Ophthalmol Glaucoma*. [Epidemiology / Natural History]
Tuuminen R (2026). [PMID: 40661044](https://pubmed.ncbi.nlm.nih.gov/40661044/). *Acta Ophthalmol*. [Diagnostic / Biomarker]
Wang B (2026). [PMID: 41526472](https://pubmed.ncbi.nlm.nih.gov/41526472/). *Sci Rep*. [Epidemiology / Natural History]
Soto-Peleteiro A (2026). [PMID: 40971971](https://pubmed.ncbi.nlm.nih.gov/40971971/). *Rheumatology (Oxford)*. [Clinical Trial Publication]
Pieramici DJ (2025). [PMID: 40048178](https://pubmed.ncbi.nlm.nih.gov/40048178/). *JAMA Ophthalmol*. [Clinical Trial Publication]